Gyre Therapeutics, Inc.GYRENASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank79
3Y CAGR-4.3%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
-4.3%/yr
Annual compound
Percentile
P79
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
20254.74%-75.2%
202419.09%-96.7%
2023587.14%+10745.6%
20225.41%+102.5%
2021-214.01%-193.1%
2020-73.02%+9.6%
2019-80.75%-222.2%
2018-25.06%+64.2%
2017-70.06%+33.6%
2016-105.44%-